Cargando…
Capacity Planning for Batch and Perfusion Bioprocesses Across Multiple Biopharmaceutical Facilities
Production planning for biopharmaceutical portfolios becomes more complex when products switch between fed-batch and continuous perfusion culture processes. This article describes the development of a discrete-time mixed integer linear programming (MILP) model to optimize capacity plans for multiple...
Autores principales: | Siganporia, Cyrus C, Ghosh, Soumitra, Daszkowski, Thomas, Papageorgiou, Lazaros G, Farid, Suzanne S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415584/ https://www.ncbi.nlm.nih.gov/pubmed/24376262 http://dx.doi.org/10.1002/btpr.1860 |
Ejemplares similares
-
Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxin
por: Ammon, A, et al.
Publicado: (2022) -
Monoclonal Antibody Against Stromal Cell-Derived Factor 2
Publicado: (2020) -
Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture
por: Pollock, James, et al.
Publicado: (2017) -
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2019) -
Monoclonal antibodies against muscle actin isoforms: epitope identification and analysis of isoform expression by immunoblot and immunostaining in normal and regenerating skeletal muscle
por: Chaponnier, Christine, et al.
Publicado: (2016)